Trends in Cardiovascular Medicine
Volume 16, Issue 4 , Pages 109-114 , May 2006

Nitric-Oxide-Induced Vasodilatation: Regulation by Physiologic S-Glutathiolation and Pathologic Oxidation of the Sarcoplasmic Endoplasmic Reticulum Calcium ATPase

  • Richard A. Cohen

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Richard A. Cohen, MD, Director, Vascular Biology Unit, Boston University Medical Center, 650 Albany Street X708, Boston, MA 02118. Tel.: (+1) 617-638-7115/7113; fax: (+1) 617-638-7115/7113.
  • ,
  • Takeshi Adachi

References 

  1. Adachi T, Cohen RA. Decreased aortic glutathione levels may contribute to impaired nitric oxide-induced relaxation in hypercholesterolaemia. Br J Pharmacol. 2000;129:1014–1020
  2. Adachi T, Matsui R, Weisbrod RM, et al. Reduced sarco/endoplasmic reticulum Ca2+ uptake activity can account for the reduced response to NO, but not sodium nitroprusside, in hypercholesterolemic rabbit aorta. Circulation. 2001;104:1040–1045
  3. Adachi T, Matsui R, Xu S, et al. Antioxidant improves smooth muscle sarco/endoplasmic reticulum Ca(2+)-ATPase function and lowers tyrosine nitration in hypercholesterolemia and improves nitric oxide-induced relaxation. Circ Res. 2002;90:1114–1121
  4. Adachi T, Pimentel DR, Heibeck T, et al. S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. J Biol Chem. 2004;279:29857–29862
  5. Adachi T, Weisbrod RM, Pimentel D, et al. S-glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. A mechanism targeted by oxidants in vascular disease. Nat Med. 2004;10:1200–1207
  6. Adachi T, Schoneich C, Cohen RA. S-glutathiolation in redox-sensitive signaling. Drug Discov Today. 2005;2:39–46
  7. Babu GJ, Periasamy M. Transgenic mouse models for cardiac dysfunction by a specific gene manipulation. Methods Mol Med. 2005;112:365–377
  8. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996;271:C1424–C1437
  9. Belke DD, Dillmann WH. Altered cardiac calcium handling in diabetes. Curr Hypertens Rep. 2004;6:424–429
  10. Bishop JE, Squier TC, Bigelow DJ, Inesi G. (Iodoacetamido)fluorescein labels a pair of proximal cysteines on the Ca2+-ATPase of sarcoplasmic reticulum. Biochemistry. 1988;27:5233–5240
  11. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, et al. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle cells. Nature. 1994;368:850–853
  12. Bu-Soud HM, Hazen SL. Nitric oxide is a physiological substrate for mammalian peroxidases. J Biol Chem. 2000;275:37524–37532
  13. Chu Y, Alwahdani A, Iida S, et al. Vascular effects of the human extracellular superoxide dismutase R213G variant. Circulation. 2005;112:1047–1053
  14. Clavreul N, Adachi T, Pimentel DR, et al. S-glutathiolation by peroxynitrite of p21ras at cysteine-118 mediates its direct activation and downstream signaling in endothelial cells. FASEB J. 2006;[10.1096/fj.05-4875fje, January 23, 2006]
  15. Cohen RA. The potential clinical impact of 20 years of nitric oxide research. Am J Physiol. 1999;276:H1404–H1407
  16. Cohen RA, Weisbrod RM, Gericke M, et al. Mechanism of nitric oxide-induced vasodilatation. Refilling of intracellular stores by sarcoplasmic reticulum Ca2+ ATPase and inhibition of store-operated Ca2+ influx. Circ Res. 1999;84:210–219
  17. Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic heart disease. N Engl J Med. 1997;337:408–416
  18. Finkel T. Redox-dependent signal transduction. FEBS Lett. 2000;476:52
  19. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408:239–247
  20. Ignarro LJ, Napoli C, Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res. 2002;90:21–28
  21. Papp B, Brouland JP, Gelebart P, et al. Endoplasmic reticulum calcium transport ATPase expression during differentiation of colon cancer and leukaemia cells. Biochem Biophys Res Commun. 2004;322:1223–1236
  22. Stamler JS, lamas S, Fang FC. Nitrosylation: the prototypic redox-based signaling mechanism. Cell. 2001;106:675–683
  23. Suwaidi JA, Hamasaki S, Higano ST, et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101:948–954
  24. Vangheluwe P, Raeymaekers L, Dode L, Wuytack F. Modulating sarco(endo)plasmic reticulum Ca2+ ATPase 2 (SERCA2) activity: cell biological implications. Cell Calcium. 2005;38:291–302
  25. Vita JA. Endothelial function and clinical outcome. Heart. 2005;91:1278–1279
  26. Yamawaki H, Haendeler J, Berk BC. Thioredoxin: a key regulator of cardiovascular homeostasis. Circ Res. 2003;93:1029–1033

PII: S1050-1738(06)00020-X

doi: 10.1016/j.tcm.2006.02.001

Trends in Cardiovascular Medicine
Volume 16, Issue 4 , Pages 109-114 , May 2006